Evidence map›Paper›PMID 42774404›Full record

ReviewSynthetic and systems biotechnology2027

Genetic engineering of cyanophages for harmful cyanobacterial bloom treatment-A mini review.

Erin E Peters, Ping Gong

Abstract readReview
In one paragraph

Review in Synthetic and systems biotechnology, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Erin E PetersEnvironmental Laboratory, US Army Engineer Research and Development Center, 3909 Halls Ferry Road, Vicksburg, MS, 39180, USA.
Ping GongEnvironmental Laboratory, US Army Engineer Research and Development Center, 3909 Halls Ferry Road, Vicksburg, MS, 39180, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Harmful cyanobacterial blooms (HCBs) are a prominent worldwide environmental concern. Proliferation of HCBs outpaces the development of mitigation and management technologies. Recently, cyanophages began to emerge as a potential abundant resource that can be harnessed for target-specific HCB treatment. However, there exist two major technical barriers in applying cyanophage-based treatment to HCB mitigation: host specificity and lysogenic life cycle. This minireview attempts to parse documented studies that developed or applied genetic engineering approaches or technologies to tackle the barriers through expanding host range and bypassing or abolishing the lysogenic life stage. We summarized representative technical approaches that may be extrapolated from bacteriophage to cyanophage, discussed genes and pathways that regulate host binding and infection or determine the switch between lytic and lysogenic lifecycles, identified existing knowledge and technological gaps and challenges, and proposed some attainable solutions and future perspectives for this fast-growing field of engineered cyanophage-mediated HCB remediation.

Indexed as

CyanophageGenetic engineeringHarmful cyanobacterial blooms (HCBs)HCB mitigationHost specificityLysogeny

Identifiers

PMID42774404
PMCPMC13594529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.